Purification and characterization of galactocerebrosidase from human lymphocytes
- PMID: 7852280
- DOI: 10.1093/oxfordjournals.jbchem.a124569
Purification and characterization of galactocerebrosidase from human lymphocytes
Abstract
Galactocerebrosidase was purified about 22,600-fold using several hydrophobic column and gel filtration steps with a 4.8% recovery, from human lymphocytes. Its specific activity was 1.54 x 10(5) nmol/h/mg with tritium-labeled galactocerebroside as the substrate in the taurocholate system. The optimal pH for galactocerebroside was 4.2 in the taurocholate system and 4.6 in the cholate system. The Km values for galactocerebroside were 5 microM in the taurocholate system and 25 microM in the cholate system. The molecular weight of the purified enzyme was estimated to be 90 kDa by sodium dodecylsulfate polyacrylamide gel electrophoresis and gel filtration. However, 70, 50, 40, and 30 kDa bands were also recognized on SDS-PAGE. The N-terminal amino acid sequences of the 70 kDa molecule and the three 50 kDa molecules were the same as that of the 90 kDa molecule. The N-terminal amino acid sequences of the 40 and 30 kDa molecules were unique. A monoclonal antibody raised against the purified enzyme effectively immunoprecipitated galactocerebrosidase activity, and an affinity column prepared with this monoclonal antibody bound the 90 and 50 kDa proteins. These results suggest that this enzyme is probably processed from the 90 kDa protein.
Similar articles
-
Galactocerebrosidase from human urine: purification and partial characterization.Biochim Biophys Acta. 1993 Sep 29;1170(1):53-61. doi: 10.1016/0005-2760(93)90175-9. Biochim Biophys Acta. 1993. PMID: 8399327
-
Krabbe disease: isolation and characterization of a full-length cDNA for human galactocerebrosidase.Biochem Biophys Res Commun. 1994 Jan 28;198(2):485-91. doi: 10.1006/bbrc.1994.1071. Biochem Biophys Res Commun. 1994. PMID: 8297359
-
Purification and first characterization of the secreted and cellular 52-kDa proteins regulated by estrogens in human-breast cancer cells.Eur J Biochem. 1986 Dec 1;161(2):505-12. doi: 10.1111/j.1432-1033.1986.tb10471.x. Eur J Biochem. 1986. PMID: 3780754
-
Purification and characterization of phosphoinositide-specific phospholipase C from bovine iris sphincter smooth muscle.Biochem J. 1993 Jan 15;289 ( Pt 2)(Pt 2):401-9. doi: 10.1042/bj2890401. Biochem J. 1993. PMID: 8380992 Free PMC article.
-
Purification and characterization of guanosine 3',5'-monophosphate-inhibited low K(m) adenosine 3',5'-monophosphate phosphodiesterase from human placental cytosolic fractions.Endocrinology. 1992 Jun;130(6):3265-74. doi: 10.1210/endo.130.6.1317779. Endocrinology. 1992. PMID: 1317779
Cited by
-
Molecular heterogeneity of Krabbe disease.J Inherit Metab Dis. 1999 Apr;22(2):155-62. doi: 10.1023/a:1005449919660. J Inherit Metab Dis. 1999. PMID: 10234611
-
Structural snapshots illustrate the catalytic cycle of β-galactocerebrosidase, the defective enzyme in Krabbe disease.Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20479-84. doi: 10.1073/pnas.1311990110. Epub 2013 Dec 2. Proc Natl Acad Sci U S A. 2013. PMID: 24297913 Free PMC article.
-
Molecular Mechanisms of Disease Pathogenesis Differ in Krabbe Disease Variants.Traffic. 2016 Aug;17(8):908-22. doi: 10.1111/tra.12404. Epub 2016 May 30. Traffic. 2016. PMID: 27126738 Free PMC article.
-
Transduction of cultured oligodendrocytes from normal and twitcher mice by a retroviral vector containing human galactocerebrosidase (GALC) cDNA.Neurochem Res. 1999 Feb;24(2):287-93. doi: 10.1023/a:1022574323784. Neurochem Res. 1999. PMID: 9972877
-
Distinguishing the differences in β-glycosylceramidase folds, dynamics, and actions informs therapeutic uses.J Lipid Res. 2018 Dec;59(12):2262-2276. doi: 10.1194/jlr.R086629. Epub 2018 Oct 2. J Lipid Res. 2018. PMID: 30279220 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases